Associated Papers
Parkinson's Disease with a Novel OPA1 Mutation Successfully Treated with Deep Brain Stimulation.
Luiso F et al.
Movement Disorders Clinical Practice, 2025
Induced Pluripotent Stem Cells for Inherited Optic Neuropathies-Disease Modeling and Therapeutic Development.
Harvey JP et al.
Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-ophthalmology Society, 2022
Nuclear Genes Associated with Mitochondrial DNA Processes as Contributors to Parkinson's Disease Risk.
Müller-Nedebock AC et al.
Movement Disorders : Official Journal of the Movement Disorder Society, 2021
Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson's Disease Models.
Iannielli A et al.
Cell Reports, 2018
29466734 (PubMed )
Supplement: mmc2.pdf
Syndromic parkinsonism and dementia associated with OPA1 missense mutations.
Carelli V et al.
Annals of Neurology, 2015
Multi-system neurological disease is common in patients with OPA1 mutations.
Yu-Wai-Man P et al.
Brain : a Journal of Neurology, 2010
Select a paper to view details